Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment
about
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.Hepatitis C virus proteinsComparison of amplification enzymes for Hepatitis C Virus quasispecies analysisHepatitis C virus molecular evolution: transmission, disease progression and antiviral therapyThe hepatitis C virus glycan shield and evasion of the humoral immune responseMolecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitisAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesBasic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoproteinViral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate InteractionSignificance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral OutcomeAnalysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated ControlsThe Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope ProteinHigh-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density LipoproteinHepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationCharacterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C VirusExpression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 BindingDivergent and convergent evolution after a common-source outbreak of hepatitis C virusHepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis CGenetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus RibavirinEvidence of Recombination in Intrapatient Populations of Hepatitis C VirusSeparation of Hepatitis C genotype 4a into IgG-depleted and IgG-enriched fractions reveals a unique quasispecies profileLow pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus ParticlesCS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular DeterminantsHepatitis C virus antigenic convergenceBinding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.HCV infection of the transplanted liver: changing CD81 and HVR1 variants immediately after liver transplantation.Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes.Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome displayHepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.Structural basis for broad neutralization of hepatitis C virus quasispecies.Human liver transplantation as a model to study hepatitis C virus pathogenesisHepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapyAnalysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by ultradeep pyrosequencing.Dynamic coinfection with multiple viral subtypes in acute hepatitis C.Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.Prediction of linear B-cell epitopes of hepatitis C virus for vaccine development
P2860
Q24307963-C7CB6BE8-D444-4D14-8869-D47AE691C683Q24563969-CD32E359-AF8E-462D-9F1A-715F588ED464Q24800738-FF1FF14B-92A5-49E8-9499-0353FD505DDCQ26853500-04614CCE-8F8A-44EB-824E-88A832776C39Q27023390-4147D65C-7B22-45AD-868B-805CDD290EFCQ27469459-D604ECEC-45B7-42FF-9870-160647F8401EQ27469837-21E163DD-D609-4CC1-8494-0739F909E501Q27472768-A106B06C-4DE5-4465-925C-856460CB3477Q27472893-CF854182-C33A-4404-B715-9192D10F3D19Q27473461-4BFB8259-41E3-43BB-B60C-6B6163E665A3Q27477606-BE8312BB-44AB-4983-B987-0643DB610C9DQ27478087-484771B4-AA90-48D7-807B-FC4DBCF30D31Q27480341-BCD8008A-25A4-4624-91F5-DE9FB59755FAQ27481009-8CF44E75-F162-428A-B996-4EE8185D95B8Q27481010-78144BA4-0998-4A20-A49A-D8F4576BB0BFQ27481012-0BA3B344-5358-4259-AAB6-CCB32B0BFDE3Q27481024-FC9A65E5-276E-4248-9029-159358EE441DQ27481026-702A5092-05DD-4441-BFCC-8E34E24DE26DQ27485216-1BA73EF8-FDBF-40F5-AC2E-19E9271FC5C6Q27486537-F0BBDEBE-B717-4415-8F46-C4F0098376DCQ27486648-31968E3C-D7CB-4F00-BAF5-FD229E4E9DE6Q27486806-C5DFD41F-38BA-4D03-920B-3C46C9396437Q27487004-5E796D77-9B43-4EF9-9EA6-177413F522E3Q27489056-B178AEDD-AE8B-498D-8595-8D0F8909092FQ27490421-AC3A2C41-F196-4B3C-B94B-5A277E994ED8Q27490535-973C7424-07C6-4121-BA7E-79A94102CD4BQ28732097-42AF6317-45B8-48CB-A558-EF4AB271E7D0Q29048140-1E17C0B7-E64C-4237-B417-28E01D88185EQ30438047-82A318BF-E26D-4BF9-9940-AFCF4F1D200CQ30758796-AAABC1F6-CF20-457D-9264-5B3C822D31B4Q33579851-D51415A8-FF3F-4A95-9843-1670C841E443Q33877342-F1DD6F6A-876E-4170-A5D3-CED2B2FE7D60Q33890011-890B3F48-B0D0-4237-9C72-F25E30CBFEACQ34064882-A86E548A-DCE2-40D4-81DE-F35B1F7DE1DFQ34197528-115977F5-C866-4D13-938A-94E15D38676AQ34316603-E3EF4B34-08C7-4205-BDE0-74CBAA2D0EAFQ34594027-B90B7332-995B-4DE4-BD7A-ABDFAD1405DCQ35022787-CE8E43CF-1EA5-453E-AB48-30B52940BD8BQ35053127-78E74890-C675-4F86-BDA2-0404E09160A6Q35872361-A4E399C8-8F6A-42E8-8EF3-9DC8AF0E2B1D
P2860
Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Conservation of the Conformati ...... s to a Role in Cell Attachment
@ast
Conservation of the Conformati ...... s to a Role in Cell Attachment
@en
Conservation of the Conformati ...... s to a Role in Cell Attachment
@nl
type
label
Conservation of the Conformati ...... s to a Role in Cell Attachment
@ast
Conservation of the Conformati ...... s to a Role in Cell Attachment
@en
Conservation of the Conformati ...... s to a Role in Cell Attachment
@nl
prefLabel
Conservation of the Conformati ...... s to a Role in Cell Attachment
@ast
Conservation of the Conformati ...... s to a Role in Cell Attachment
@en
Conservation of the Conformati ...... s to a Role in Cell Attachment
@nl
P2093
P2860
P3181
P1433
P1476
Conservation of the Conformati ...... s to a Role in Cell Attachment
@en
P2093
G Germanidis
J M Pawlotsky
P O Frainais
P2860
P304
P3181
P356
10.1128/JVI.75.12.5703-5710.2001
P577
2001-06-01T00:00:00Z